动脉自旋标记测对侧半球脑血流可预测急性卒中结局
结果显示,校正基线NIHSS、DWI病灶体积和动脉内治疗后,较高cCBF仍显著预测90天良好功能结局(OR 4.6,95%CI 1.4-14.7,P=0.01)。
要点
- 对侧半球cCBF较高与90天良好功能结局独立相关。
- cCBF或可辅助卒中分诊、治疗决策和预后判断。
核心结论
- 基线较高的定量对侧半球脑血流是90天良好神经功能结局的显著预测因子。
主要发现
- cCBF中位数为38.9(31.2-44.5)mL/100g/min,按中位数分为高、低cCBF组。
- 较高cCBF预测90天良好结局的OR为4.6(95%CI 1.4-14.7),P=0.01,校正基线NIHSS、DWI病灶体积和动脉内治疗后仍显著。
关键数值与推荐
- 纳入标准:前循环缺血性卒中,基线NIHSS≥1,病前mRS≤2,发病至成像时间<24小时,成像包含DWI和动脉自旋标记。
- 结局评估:第1天和第5天NIHSS;第30天和第90天mRS;良好神经功能结局定义为90天mRS 0-2。
临床怎么用
- cCBF水平可能为卒中分诊、急性卒中治疗决策和总体预后判断提供信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Imaging is frequently used to select acute stroke patients for intra-arterial therapy. Quantitative cerebral blood flow can be measured noninvasively with arterial spin labeling magnetic resonance imaging. Cerebral blood flow levels in the contralateral (unaffected) hemisphere may affect capacity for collateral flow and patient outcome. The goal of this study was to determine whether higher contralateral cerebral blood flow (cCBF) in acute stroke identifies patients with better 90-day functional outcome. Methods- Patients were part of the prospective, multicenter iCAS study (Imaging Collaterals in Acute Stroke) between 2013 and 2017. Consecutive patients were enrolled after being diagnosed with anterior circulation acute ischemic stroke. Inclusion criteria were ischemic anterior circulation stroke, baseline National Institutes of Health Stroke Scale score ≥1, prestroke modified Rankin Scale score ≤2, onset-to-imaging time <24 hours, with imaging including diffusion-weighted imaging and arterial spin labeling. Patients were dichotomized into high and low cCBF groups based on median cCBF. Outcomes were assessed by day-1 and day-5 National Institutes of Health Stroke Scale; and day-30 and day-90 modified Rankin Scale. Multivariable logistic regression was used to test whether cCBF predicted good neurological outcome (modified Rankin Scale score, 0-2) at 90 days. Results- Seventy-seven patients (41 women) met the inclusion criteria with median (interquartile range) age of 66 (55-76) yrs, onset-to-imaging time of 4.8 (3.6-7.7) hours, and baseline National Institutes of Health Stroke Scale score of 13 (9-20). Median cCBF was 38.9 (31.2-44.5) mL per 100 g/min. Higher cCBF predicted good outcome at day 90 (odds ratio, 4.6 [95% CI, 1.4-14.7]; P=0.01), after controlling for baseline National Institutes of Health Stroke Scale, diffusion-weighted imaging lesion volume, and intra-arterial therapy. Conclusions- Higher quantitative cCBF at baseline is a significant predictor of good neurological outcome at day 90. cCBF levels may inform decisions regarding stroke triage, treatment of acute stroke, and general outcome prognosis. Clinical Trial Registration- URL: https://www.clinicaltrials.gov. Unique identifier: NCT02225730.
引用
- Thamm T, Guo J, Rosenberg J, et al. Contralateral Hemispheric Cerebral Blood Flow Measured With Arterial Spin Labeling Can Predict Outcome in Acute Stroke. Stroke. 2019. PMID: 31619150. doi:10.1161/STROKEAHA.119.026499
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。